83 - Clinical Controversies on the Frontline of the HIV Clinic

Debate Style Speaker(s)

• 

  Roger Bedimo, MD

  Professor of Medicine
  VA North Texas Health Care System
  Dallas, Texas

  Disclosure: Gilead Sciences : Consultant (Status: Terminated --- 11/07/2019); Merck & Co : Advisor or Review Panel member (Status: Ongoing); ViiV Healthcare : Advisor or Review Panel member (Status: Ongoing), Research Grant or Support (Status: Ongoing)
• JC

  Jonathan Colasanti, MD

  Emory University, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Grace McComsey, MD

  Professor and Vice President of Research
  University Hospitals of Cleveland, Case Western Reserve University
  Cleveland, Ohio

  Disclosure: Does Disclose
• 

  Aadia Rana, MD

  Associate Professor of Medicine
  University of Alabama-Birmingham School of Medicine, AL

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Learning Objectives:

• describe the benefits and potential risks of long-acting antiretroviral for some patients with HIV
• assess the pros and cons of maintaining patients with HIV on integrase inhibitors at risk for weight gain

Presentations:

• 2:45pm – 4:00pm EDT

  Integrase Inhibitors and Weight Gain -- to Switch or Not to Switch?
  Roger Bedimo, MD – VA North Texas Health Care System
• 2:45pm – 4:00pm EDT

  Integrase Inhibitors and Weight Gain -- to Switch or Not to Switch?
  Grace A. McComsey, MD – University Hospitals of Cleveland, Case Western Reserve University
• 2:45pm – 4:00pm EDT

  Long-acting Antiretrovirals – the Wave of the Future?
  Jonathan Colasanti, MD – Emory University
• 2:45pm – 4:00pm EDT

  Long-acting Antiretrovirals – the Wave of the Future?
  Aadia Rana, MD – University of Alabama-Birmingham School of Medicine